Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Treatment of rheumatoid arthritis with etanercept RHEUMATIC DISEASE CLINICS OF NORTH AMERICA Genovese, M. C., Kremer, J. M. 2004; 30 (2): 311-?

Abstract

Etanercept is effective in the treatment of rheumatoid arthritis (RA)when used as monotherapy and in combination with methotrexate(MTX). Radiographic progression of disease was slowed significantly when the drug was used for a 24-month period and was statistically significantly better than MTX. In addition to its use in RA,etanercept is approved by the U.S. Food and Drug Administration for other rheumatologic conditions, including psoriatic arthritis,ankylosing spondylitis, and juvenile chronic arthritis.

View details for DOI 10.1016/j.rdc.2004.01.004

View details for Web of Science ID 000221971000007

View details for PubMedID 15172043